tiprankstipranks
Advertisement
Advertisement

KPTI Stock Latest News

KPTI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsKPTI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5d ago
KPTI
Karyopharm price target raised to $16 from $8 at Piper Sandler
PremiumThe Fly
Karyopharm price target raised to $16 from $8 at Piper Sandler
6d ago
KPTI
Karyopharm price target lowered to $16 from $23 at RBC Capital
PremiumThe Fly
Karyopharm price target lowered to $16 from $23 at RBC Capital
26d ago
KPTI
Karyopharm price target lowered to $8 from $12 at Piper Sandler
PremiumThe Fly
Karyopharm price target lowered to $8 from $12 at Piper Sandler
1M ago
KPTI
Karyopharm Strengthens Liquidity With New Equity Financing
PremiumCompany Announcements
Karyopharm Strengthens Liquidity With New Equity Financing
1M ago
8K
KPTI
Karyopharm price target lowered to $15 from $21 at Baird
PremiumThe FlyKaryopharm price target lowered to $15 from $21 at Baird
1M ago
KPTI
Karyopharm price target lowered to $8 from $15 at H.C. Wainwright
Premium
The Fly
Karyopharm price target lowered to $8 from $15 at H.C. Wainwright
1M ago
KPTI
Karyopharm Announces Financing and Positive SENTRY Trial Results
Premium
Company Announcements
Karyopharm Announces Financing and Positive SENTRY Trial Results
1M ago
8K
KPTI
Karyopharm up 23% after Phase 3 SENTRY trial meets first co-primary endpoint
PremiumThe Fly
Karyopharm up 23% after Phase 3 SENTRY trial meets first co-primary endpoint
1M ago
KPTI
Karyopharm’s Phase 3 SENTRY trial meets first co-primary endpoint
PremiumThe Fly
Karyopharm’s Phase 3 SENTRY trial meets first co-primary endpoint
1M ago
KPTI
Karyopharm announces $30M private placement
PremiumThe Fly
Karyopharm announces $30M private placement
1M ago
KPTI
Karyopharm initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Karyopharm initiated with a Buy at Rodman & Renshaw
2M ago
KPTI
Karyopharm Amends Credit Agreement to Extend Liquidity Runway
PremiumCompany AnnouncementsKaryopharm Amends Credit Agreement to Extend Liquidity Runway
2M ago
8K
KPTI
Karyopharm Shareholders Approve Major Authorized Share Increase
Premium
Company Announcements
Karyopharm Shareholders Approve Major Authorized Share Increase
2M ago
8K
KPTI
Buy Rating Reaffirmed on De‑Risked SENTRY Readout and Undervalued Selinexor Cash Flow Potential
Premium
Ratings
Buy Rating Reaffirmed on De‑Risked SENTRY Readout and Undervalued Selinexor Cash Flow Potential
2M ago
KPTI
Karyopharm Therapeutics Faces Rising Regulatory and Political Risks Amid Supreme Court Limits on FDA Authority
PremiumCompany Announcements
Karyopharm Therapeutics Faces Rising Regulatory and Political Risks Amid Supreme Court Limits on FDA Authority
3M ago
KPTI
Karyopharm Earnings Call: Pivotal Data Amid Cash Squeeze
PremiumCompany Announcements
Karyopharm Earnings Call: Pivotal Data Amid Cash Squeeze
3M ago
KPTI
Karyopharm reports Q4 EPS ($5.71) vs. ($3.67) last year
PremiumThe Fly
Karyopharm reports Q4 EPS ($5.71) vs. ($3.67) last year
3M ago
KPTI
Karyopharm sees 2026 revenue $130M-$150M, consensus $146.86M
PremiumThe Fly
Karyopharm sees 2026 revenue $130M-$150M, consensus $146.86M
3M ago
KPTI
KPTI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsKPTI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
KPTI
Karyopharm initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Karyopharm initiated with an Overweight at Cantor Fitzgerald
3M ago
KPTI
Karyopharm Issues Preliminary 2025 Financial Results and Outlook
Premium
Company Announcements
Karyopharm Issues Preliminary 2025 Financial Results and Outlook
4M ago
8K
KPTI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >